Cite
HARVARD Citation
Morita, A. et al. (2021). Dacomitinib as a retreatment for advanced non‐small cell lung cancer patient with an uncommon EGFR mutation. Thoracic cancer. 12 (8), pp. 1248-1251. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Morita, A. et al. (2021). Dacomitinib as a retreatment for advanced non‐small cell lung cancer patient with an uncommon EGFR mutation. Thoracic cancer. 12 (8), pp. 1248-1251. [Online].